Authors:
Langer, O
Dolle, F
Valette, H
Halldin, C
Vaufrey, F
Fuseau, C
Coulon, C
Ottaviani, M
Nagren, K
Bottlaender, M
Maziere, B
Crouzel, C
Citation: O. Langer et al., Synthesis of high-specific-radioactivity 4- and 6-[F-18]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart, BIO MED CH, 9(3), 2001, pp. 677-694
Authors:
Holopainen, IE
Metsahonkala, EL
Kokkonen, H
Parkkola, RK
Manner, TE
Nagren, K
Korpi, ER
Citation: Ie. Holopainen et al., Decreased binding of [C-11]flumazenil in Angelman syndrome patients with GABA(A) receptor beta(3) subunit deletions, ANN NEUROL, 49(1), 2001, pp. 110-113
Authors:
Sutinen, E
Jyrkkio, S
Gronroos, T
Haaparanta, M
Lehikoinen, P
Nagren, K
Citation: E. Sutinen et al., Biodistribution of [C-11]methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo, EUR J NUCL, 28(7), 2001, pp. 847-854
Authors:
Ukkonen, H
Knuuti, J
Katoh, C
Iida, H
Sipila, H
Lehikoinen, P
Nagren, K
Voipio-Pulkki, LM
Citation: H. Ukkonen et al., Use of [C-11]acetate and [O-15]O-2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction, EUR J NUCL, 28(3), 2001, pp. 334-339
Authors:
Pietila, M
Malminiemi, K
Ukkonen, H
Saraste, M
Nagren, K
Lehikoinen, P
Volpio-Pulkki, LM
Citation: M. Pietila et al., Reduced myocardial carbon-11 hydroxyephedrine retention is associated withpoor prognosis in chronic heart failure, EUR J NUCL, 28(3), 2001, pp. 373-376
Authors:
Langer, O
Halldin, C
Chou, YH
Sandell, J
Swahn, CG
Nagren, K
Perrone, R
Berardi, F
Leopoldo, M
Farde, L
Citation: O. Langer et al., Carbon-11 PB-12: An attempt to visualize the dopamine D-4 receptor in the primate brain with positron emission tomography, NUCL MED BI, 27(8), 2000, pp. 707-714
Authors:
Oikonen, V
Allonen, T
Nagren, K
Kajander, J
Hietala, J
Citation: V. Oikonen et al., Quantification of [carbonyl-C-11]WAY-100635 binding: Considerations on thecerebellum, NUCL MED BI, 27(5), 2000, pp. 483-486
Authors:
Krasikova, R
Fedorova, O
Korsakov, M
Nagren, K
Maziere, B
Halldin, C
Citation: R. Krasikova et al., A fast and convenient method for robotic preparation of [C-11]flumazenil avoiding HPLC purification, J LABEL C R, 43(6), 2000, pp. 613-621
Authors:
Kamarainen, EL
Kyllonen, T
Airaksinen, A
Lundkvist, C
Yu, MX
Nagren, K
Sandell, J
Langer, O
Vepsalainen, J
Hiltunen, J
Bergstrom, K
Lotjonen, S
Jaakkola, T
Halldin, C
Citation: El. Kamarainen et al., Preparation of [F-18]beta-CFT-FP and [C-11]beta-CFT-FP, selective radioligands for visualisation of the dopamine transporter using positron emission tomography (PET), J LABEL C R, 43(12), 2000, pp. 1235-1244
Citation: K. Nagren et al., [N-methyl-C-11]MeAIB, a tracer for system A amino acid transport: Preparation from [C-11]methyl triflate and HPLC metabolite analysis of plasma samples after intravenous administration in man., J LABEL C R, 43(10), 2000, pp. 1013-1021
Authors:
Vilkman, H
Kajander, J
Nagren, K
Oikonen, V
Syvalahti, E
Hietala, J
Citation: H. Vilkman et al., Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis, EUR J NUCL, 27(11), 2000, pp. 1666-1673
Authors:
Kaasinen, V
Vilkman, H
Hietala, J
Nagren, K
Helenius, H
Olsson, H
Farde, L
Rinne, JO
Citation: V. Kaasinen et al., Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain, NEUROBIOL A, 21(5), 2000, pp. 683-688
Authors:
Kaasinen, V
Ruottinen, HM
Nagren, K
Lehikoinen, P
Oikonen, T
Rinne, JO
Citation: V. Kaasinen et al., Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone, J NUCL MED, 41(1), 2000, pp. 65-70
Authors:
Kemppainen, N
Ruottinen, H
Nagren, K
Rinne, JO
Citation: N. Kemppainen et al., PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD, NEUROLOGY, 55(2), 2000, pp. 205-209
Authors:
Kaasinen, V
Nagren, K
Hietala, J
Oikonen, V
Vilkman, H
Farde, L
Halldin, C
Rinne, JO
Citation: V. Kaasinen et al., Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease, NEUROLOGY, 54(7), 2000, pp. 1482-1487
Authors:
Lamusuo, S
Pitkanen, A
Jutila, L
Ylinen, A
Partanen, K
Kalviainen, R
Ruottinen, HM
Oikonen, V
Nagren, K
Lehikoinen, P
Vapalahti, M
Vainio, P
Rinne, JO
Citation: S. Lamusuo et al., [C-11]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy - Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology, NEUROLOGY, 54(12), 2000, pp. 2252-2260
Authors:
Kanerva, H
Vilkman, H
Nagren, K
Kilkku, O
Kuoppamaki, M
Syvalahti, E
Hietala, J
Citation: H. Kanerva et al., Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study, PSYCHOPHAR, 145(1), 1999, pp. 76-81
Authors:
Pohjalainen, T
Nagren, K
Syvalahti, EKG
Hietala, J
Citation: T. Pohjalainen et al., The dopamine D-2 receptor 5 '-flanking variant, C-141 Ins/Del, is not associated with reduced dopamine D-2 receptor density in vivo, PHARMACOGEN, 9(4), 1999, pp. 505-509
Authors:
Langer, O
Nagren, K
Dolle, F
Lundkvist, C
Sandell, J
Swahn, CG
Vaufrey, F
Crouzel, C
Maziere, B
Halldin, C
Citation: O. Langer et al., Precursor synthesis and radiolabelling of the dopamine D-2 receptor ligand[C-11]raclopride from [C-11]methyl triflate, J LABEL C R, 42(12), 1999, pp. 1183-1193
Authors:
Hietala, J
Nagren, K
Lehikoinen, P
Ruotsalainen, U
Syvalahti, E
Citation: J. Hietala et al., Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis, J CEREBR B, 19(2), 1999, pp. 210-217
Authors:
Vesalainen, RK
Pietila, M
Tahvanainen, KUO
Jartti, T
Teras, M
Nagren, K
Lehikoinen, P
Huupponen, R
Ukkonen, H
Saraste, M
Knuuti, J
Voipio-Pulkki, LM
Citation: Rk. Vesalainen et al., Cardiac positron emission tomography imaging with [C-11]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure, AM J CARD, 84(5), 1999, pp. 568-574